Statistical Significance: Could Small Pharma Companies be making more of Safety Signal Detection?
It’s becoming increasingly clear that minimal signal detection is not cutting it, when it comes to doing the best for patients and staying ahead of…
It’s becoming increasingly clear that minimal signal detection is not cutting it, when it comes to doing the best for patients and staying ahead of…
AI enabled pharmacovigilance isn’t just about absorbing extra AE case volumes without driving up costs to maintain compliance and mitigate risk. It is also crucial…
Monitoring in-country medical literature is an essential aspect of pharmacovigilance, providing an early pointer to adverse events in specific populations. Yet traditionally the process is…
Smart analytics applied to real-world data are increasingly enabling companies to track adverse effects, while at the same time identifying opportunities for drug repurposing. ArisGlobal’s…
As well as exposing companies to non-compliance, inefficiency and delays, a manually-maintained pharmacovigilance system master file (PSMF) limits visibility and transparency. Christian Schmitz-Moormann, a senior…